Professor Mike Barnes has said that the draft guidance from the National Institute for Health and Care Excellence (NICE) on cannabis-based medical products (CBMPs) is “appalling”. Published this week, NICE
A small number of patients are to be given cannabis medicine prescriptions as part of a UK trial to test their effectiveness. GW Pharmaceuticals have offered an early access programme
How do we work around the problem of adhering to some of the most strict medical guidelines in the world for medicine and at the same time help those that
The Centre for Medical Cannabis (CMC), a new lobbying organisation which launched on Monday 10 December at the Academy of Medical Sciences, has said that it isn’t yet recommending decriminalisation
The National Institute for Health and Care Excellence (NICE) has published a draft scope for its upcoming guidelines on cannabis-based products for medicinal use. Out for consultation between 13 November
